FindTrial
Sign In

Entwicklung einer Untersuchungsmethode zur Bestimmung des NO-Transferfaktors der Lunge Evaluierung der Methode und Normwerterhebung an gesunden Probanden (Development of a new method for steady-state measurement of NO lung diffusing capacity in healthy subjects)

Entwicklung einer Untersuchungsmethode zur Bestimmung des NO-Transferfaktors der Lunge Evaluierung der Methode und Normwerterhebung an gesunden Probanden (Development of a new method for steady-state measurement of NO lung diffusing capacity in healthy subjects)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-005678-61-DE
Enrollment
107
Registered
2005-12-29
Start date
2006-02-22
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung function testing (NO- and CO Transferfactor) in healthy subjects

Interventions

Product Name: Nitric Oxide in Nitrogen Product Code: NO Pharmaceutical Form: Inhalation gas INN or Proposed INN: Nitric Oxide Concentration unit: % percent Concentration type: equal Concentration numb

Sponsors

University Hospital Tuebingen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • voluntary healthy persons, age 6-45 years • lung function testing is possible without restriction • written informed consent Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: • pulmonary, cardiological, endocrinological or neurological illness • Participation in another clinical trial • pregnancy and nursing • uncertain contraception • abuse of nicotine, alcohol or drugs in the last 2 years

Design outcomes

Primary

MeasureTime frame
Main Objective: Main objective of the clinical trial is the evaluation of a new method (nitric oxide multiple breath) for measuring lung diffusion capacity in comparison to a standard method (single-breath carbon monoxide) as well as the survey of normative values in voluntary healthy persons. ;Secondary Objective: ;Primary end point(s): transfer factor for nitric oxide and carbon monoxide—

Countries

Germany

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026